BullFrog AI Launches bfPREP, a New AI-Powered Data Preparation Module in Its BullFrog Data Networks Solutions Library
BullFrog AI (NASDAQ: BFRG) has launched bfPREP™, a new AI-powered data preparation module within its BullFrog Data Networks™ Solutions Library. The module, developed from the company's experience in a late-stage oncology trial, addresses the challenge of preparing fragmented clinical trial data for AI analysis.
bfPREP™ targets a rapidly growing market expected to reach $6.8 billion by 2029, up from $3.1 billion in 2024. The solution features biomedical-first intelligence, end-to-end automation, standards-based interoperability, and cloud-ready deployment options. It's designed to transform raw clinical, omics, and real-world datasets into analysis-ready insights, significantly reducing data preparation time from months to days.
BullFrog AI (NASDAQ: BFRG) ha lanciato bfPREP™, un nuovo modulo di preparazione dati basato sull'intelligenza artificiale all'interno della BullFrog Data Networks™ Solutions Library. Questo modulo, sviluppato grazie all'esperienza maturata in uno studio oncologico in fase avanzata, risolve la complessità della preparazione di dati frammentati di studi clinici per l'analisi AI.
bfPREP™ si rivolge a un mercato in rapida crescita, previsto raggiungere un valore di 6,8 miliardi di dollari entro il 2029, rispetto ai 3,1 miliardi nel 2024. La soluzione offre intelligenza specifica per il settore biomedico, automazione completa, interoperabilità basata su standard e opzioni di distribuzione pronte per il cloud. È progettata per trasformare dataset clinici grezzi, omici e di dati real-world in insight pronti per l'analisi, riducendo significativamente i tempi di preparazione da mesi a giorni.
BullFrog AI (NASDAQ: BFRG) ha lanzado bfPREP™, un nuevo módulo de preparación de datos impulsado por IA dentro de la BullFrog Data Networks™ Solutions Library. Este módulo, desarrollado a partir de la experiencia de la empresa en un ensayo oncológico en fase avanzada, aborda el desafío de preparar datos fragmentados de ensayos clínicos para el análisis con IA.
bfPREP™ apunta a un mercado en rápido crecimiento que se espera alcance los 6.8 mil millones de dólares para 2029, frente a los 3.1 mil millones en 2024. La solución cuenta con inteligencia biomédica, automatización integral, interoperabilidad basada en estándares y opciones de implementación listas para la nube. Está diseñada para transformar conjuntos de datos clínicos, ómicos y del mundo real en conocimientos listos para análisis, reduciendo significativamente el tiempo de preparación de datos de meses a días.
BullFrog AI (NASDAQ: BFRG)가 BullFrog Data Networks™ 솔루션 라이브러리 내에 AI 기반 데이터 준비 모듈인 bfPREP™를 출시했습니다. 이 모듈은 후기 단계의 종양학 임상시험 경험을 바탕으로 개발되어, 분산된 임상시험 데이터를 AI 분석에 적합하게 준비하는 문제를 해결합니다.
bfPREP™는 2024년 31억 달러에서 2029년 68억 달러에 이를 것으로 예상되는 급성장 시장을 목표로 합니다. 이 솔루션은 생의학 중심의 인텔리전스, 엔드투엔드 자동화, 표준 기반 상호운용성, 클라우드 배포 옵션을 특징으로 합니다. 임상, 오믹스, 실제 데이터 세트를 분석 준비가 된 인사이트로 변환하여 데이터 준비 시간을 수개월에서 수일로 크게 단축하도록 설계되었습니다.
BullFrog AI (NASDAQ: BFRG) a lancé bfPREP™, un nouveau module de préparation des données propulsé par l'IA, intégré à la BullFrog Data Networks™ Solutions Library. Ce module, développé à partir de l'expérience de la société dans un essai oncologique avancé, répond au défi de la préparation des données fragmentées des essais cliniques pour l'analyse par IA.
bfPREP™ cible un marché en forte croissance, qui devrait atteindre 6,8 milliards de dollars d'ici 2029, contre 3,1 milliards en 2024. La solution propose une intelligence biomédicale, une automatisation complète, une interopérabilité basée sur des normes et des options de déploiement prêtes pour le cloud. Elle est conçue pour transformer des ensembles de données cliniques brutes, omiques et du monde réel en insights prêts à être analysés, réduisant ainsi considérablement le temps de préparation des données, de plusieurs mois à quelques jours.
BullFrog AI (NASDAQ: BFRG) hat bfPREP™ vorgestellt, ein neues KI-gestütztes Datenvorbereitungsmodul innerhalb der BullFrog Data Networks™ Solutions Library. Das Modul wurde auf Basis der Erfahrungen des Unternehmens in einer späten Onkologie-Studie entwickelt und bewältigt die Herausforderung, fragmentierte klinische Studiendaten für die KI-Analyse aufzubereiten.
bfPREP™ richtet sich an einen schnell wachsenden Markt, der bis 2029 voraussichtlich 6,8 Milliarden US-Dollar erreichen wird, gegenüber 3,1 Milliarden US-Dollar im Jahr 2024. Die Lösung bietet biomedizinisch orientierte Intelligenz, End-to-End-Automatisierung, standardbasierte Interoperabilität und cloud-fähige Bereitstellungsoptionen. Sie ist darauf ausgelegt, rohe klinische, Omics- und Real-World-Datensätze in analysebereite Erkenntnisse zu verwandeln und die Datenvorbereitungszeit erheblich von Monaten auf Tage zu verkürzen.
- Targets growing market projected to reach $6.8 billion by 2029
- Reduces data preparation time from months to days through automation
- Purpose-built for life sciences with domain-specific capabilities
- Seamless integration with major cloud platforms (AWS, Azure, GCP)
- Product is new and unproven in the broader market
- Faces competition in established data preparation tools market
Insights
BullFrog AI's new bfPREP module addresses a growing multi-billion dollar market opportunity in life sciences data preparation.
BullFrog AI's launch of bfPREP™ represents a strategic expansion of their product portfolio, directly targeting the $3.1 billion life sciences data preparation market that's projected to reach
What makes this product launch particularly notable is its domain-specific focus. Unlike generic data preparation tools, bfPREP™ is built with proprietary algorithms specifically for biomedical applications. The solution emerged organically from BullFrog's work on a late-stage oncology trial, where they encountered the significant challenge of preparing fragmented clinical trial data (including handwritten notes) for AI analysis.
The technical differentiation centers on four key features: biomedical-first intelligence with domain-specific data representation, end-to-end automation that reportedly reduces preparation timelines from months to days, standards-based interoperability with native OMOP support, and seamless integration with BullFrog's existing analytics environment. These capabilities directly address the "hidden bottleneck" that impairs many healthcare AI initiatives - the labor-intensive process of preparing messy, inconsistent data.
From a market positioning perspective, BullFrog is targeting multiple stakeholders across the drug development ecosystem - clinical operations teams, CROs, biotechs, and health IT managers. This broad applicability expands their potential customer base within life sciences organizations seeking to accelerate their data-driven initiatives.
With this addition to their Solutions Library, BullFrog continues its evolution from a pure AI analytics company to a more comprehensive provider of modular drug development technologies, potentially creating multiple revenue streams across the pharmaceutical development lifecycle.
New module addresses multi-billion-dollar data quality challenge in life sciences by automating data cleansing, standardization, and transformation for AI readiness
Built for scale, security, and human in the loop domain expertise, the enterprise-wide solution is poised to transform drug development for the world’s largest biopharma organizations
GAITHERSBURG, Md., July 17, 2025 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW) ("BullFrog AI" or the "Company"), a technology-enabled drug development company using artificial intelligence (“AI”) and machine learning to enable the successful development of pharmaceuticals and biologics, today announced the addition of bfPREP™, a dedicated data cleansing and preparation module, to its BullFrog Data Networks™ Solutions Library.
Born out of BullFrog AI’s work supporting a late-stage oncology trial, bfPREP™ emerged as a critical solution to a massive challenge: preparing fragmented, inconsistent clinical trial data, including handwritten notes, for advanced AI analysis. Initially developed to cleanse and standardize data as a precursor to BullFrog’s trial optimization work, the technology proved so effective that it is now its own module. Purpose-built with proprietary algorithms for life sciences and healthcare, bfPREP™ automates the detection, correction, standardization, and transformation of clinical, omics, and real-world datasets—turning raw information into analysis-ready insights.
“bfPREP™ solves the hidden bottleneck that impairs so many AI initiatives—messy data,” said Vin Singh, Founder and CEO of BullFrog AI. “What started as a bespoke solution quickly proved its broader value, and we’re proud to now offer a life sciences-native product that understands biomedical data at its core. With this new ‘volume’ in our Solutions Library, we’re giving clients a way to go from chaos to clarity, fast.”
bfPREP™ Addresses a Growing Multi-Billion-Dollar Problem
According to the Business Research Company, the global market for data preparation and cleansing tools in life sciences and healthcare is expected to grow from approximately
Key Differentiators of bfPREP™:
- Biomedical-First Intelligence – Unlike generic data prep tools, bfPREP™ pairs domain-specific data representation with AI-assisted feature augmentation to supplement raw data. These literature-backed, human-vetted transformations improve model performance and support more robust modeling.
- End-to-End Automation – Identifies anomalies, standardizes formats, and suggests transformations, reducing prep timelines from months to days.
- Standards-Based Interoperability – Native support for OMOP, with more healthcare data standards coming soon, and seamless system integration.
- Insight-Ready Pipeline – Cleaned datasets flow directly into BullFrog AI’s analytics environment, enabling immediate use in AI workflows like patient stratification, trial simulation, or target discovery.
- Modular, Scalable, and Cloud-Ready – Deployed on AWS, Azure, or GCP, bfPREP™ integrates with existing data lakes and supports hybrid environments for sensitive datasets.
Strategic Value for Clinical, R&D, and IT Teams
bfPREP™ is designed to support a wide range of users across the drug development spectrum:
- Clinical operations teams can accelerate database lock and analysis timelines.
- CROs can deliver cleaner, submission-ready data faster—with value-added analytics.
- Biotechs can turn fragmented datasets into strategic assets, reducing resource burdens.
- Health IT managers benefit from scalable automation aligned with data governance goals.
With the launch of bfPREP™, BullFrog AI continues to expand its modular Solutions Library, offering clients a flexible, plug-and-play toolkit for every phase of the drug development lifecycle.
About BullFrog AI
BullFrog AI leverages Artificial Intelligence and machine learning to advance drug discovery and development. Through collaborations with leading research institutions, BullFrog AI uses causal AI in combination with its proprietary bfLEAP™ platform to analyze complex biological data, aiming to streamline therapeutics development and reduce failure rates in clinical trials.
For more information visit BullFrog AI at: https://bullfrogai.com
Safe Harbor Statement
This press release contains forward-looking statements. We base these forward-looking statements on our expectations and projections about future events, which we derive from the information currently available to us. Such forward-looking statements relate to future events or our future performance, including: our financial performance and projections; our revenue and earnings; and our business prospects and opportunities. You can identify forward-looking statements by those that are not historical in nature, particularly those that use terminology such as "may," "should," “could,” “will,” "expects," "anticipates," "contemplates," "estimates," "believes," "plans," "projected," "predicts," "potential," or "hopes" or the negative of these or similar terms. In evaluating these forward-looking statements, you should consider various factors, including: our ability to change the direction of the Company; our ability to keep pace with new technology and changing market needs; our and our partners’ ability to market and sell our offerings and services, including BullFrog Data Networks™ and the competitive environment of our business. These and other factors may cause our actual results to differ materially from any forward-looking statement. Forward-looking statements are only predictions. The forward-looking events discussed in this press release and other statements made from time to time by us or our representatives, may not occur, and actual events and results may differ materially and are subject to risks, uncertainties, and assumptions about us. We are not obligated to publicly update or revise any forward-looking statement, whether as a result of uncertainties and assumptions, the forward-looking events discussed in this press release and other statements made from time to time by us or our representatives might not occur.
Contact:
Dave Gentry
RedChip Companies, Inc.
1-407-644-4256
BFRG@redchip.com
FAQ
What is BullFrog AI's bfPREP and when was it launched?
How large is the market opportunity for BullFrog AI's bfPREP?
What are the key features of BullFrog AI's bfPREP platform?
How does bfPREP improve data preparation efficiency?
Who are the target users for BullFrog AI's bfPREP solution?
